Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields - Pfizer (NYSE:PFE), Bristol-Myers Squibb (NYSE:BMY)

Core Insights - During market turbulence, investors often seek dividend-yielding stocks, which typically have high free cash flows and offer substantial dividends [1] Group 1: Analyst Ratings and Price Targets - Pfizer Inc (NYSE:PFE) has a dividend yield of 7.01%. Analyst Tim Anderson from B of A Securities maintained a Neutral rating and raised the price target from $28 to $30, with an accuracy rate of 75% [7] - Bristol-Myers Squibb Co (NYSE:BMY) has a dividend yield of 5.66%. Analyst Andrew Baum from Citigroup maintained a Neutral rating and decreased the price target from $51 to $47, with an accuracy rate of 70% [7] - Perrigo Company PLC (NYSE:PRGO) has a dividend yield of 5.36%. Analyst Susan Anderson from Canaccord Genuity maintained a Buy rating and cut the price target from $42 to $40, with an accuracy rate of 64% [7] Group 2: Recent News - Pfizer announced initial results from a clinical trial called HER2CLIMB-05 [7] - Bristol Myers Squibb and insitro announced the next phase of their collaboration for new treatments for amyotrophic lateral sclerosis [7] - Perrigo reported worse-than-expected second-quarter financial results [7]